Accelrys releases Discovery Studio software program for biotherapeutics research Accelrys DSE.

Accelrys releases Discovery Studio software program for biotherapeutics research Accelrys, Inc DSE . The release incorporates the initial available software for predicting protein-protein aggregation to advance biotherapeutics research commercially. As a key application in the Simulation and Modeling pillar of the Accelrys Business R&D Architecture, Discovery Studio extends comprehensive modeling and simulation features and knowledge from specialists to the enterprise, combining collaborative science from Accelrys and leading educational and research institutions on a unified platform.